MERCK

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Elichabe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2026-05-01",
      "evidence_quote": "De enige aandeelhouder beslist om met ingang van 1 mei 2026 het mandaat van Benoit Elichabe als bestuurder van de Vennootschap te be\u00EBindigen."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Susan King-Barnardo",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2026-05-01",
      "evidence_quote": "De enige aandeelhouder beslist om Susan King-Barnardo, woonst kiezende op de zetel van de Vennootschap, te benoemen als bestuurder van de Vennootschap met ingang van 1 mei 2026, en dit voor een periode van zes maanden."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Susan King-Barnardo",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2026-05-01",
      "evidence_quote": "De bestuurders nemen kennis van de benoeming van Susan King-Barnardo als bestuurder van de Vennootschap met ingang van 1 mei 2026 en beslissen om het dagelijks bestuur van de Vennootschap aan Susan King-Barnardo te delegeren overeenkomstig artikel 10, tweede lid van de statuten, met ingang van mei 2"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Spasena Yotova",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-04-01",
      "evidence_quote": "De enige aandeelhouder bevestigt de herbenoeming van mevrouw Spasena Yotova als bestuurder van de Vennootschap met ingang van 1 april 2025 en eindigend na afloop van de algemene vergadering die zal beslissen over de goedkeuring van de jaarrekening per 31 december 2029."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-10-02",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  },
  "signature_regime": "solo",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "KPMG Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De enige aandeelhouder bevestigt het verstrijken van het mandaat van de besloten vennootschap KPMG Bedrijfsrevisoren, met zetel te Luchthaven Brussel Nationaal 1K, 1930, Zaventem, vertegenwoordigd door de heer Olivier Declercq, als commissaris van de Vennootschap."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Gert Vanhees",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-06-16",
      "evidence_quote": "De enige aandeelhouder beslist de besloten vennootschap Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises, met zetel te Luchthaven Brusse! Nationaal 1J, 1930 Zaventem, te benoemen als commissaris van de Vennootschap met ingang vanaf 16 juni 2023 voor een termijn van drie (3) jaren. Het mandaat zal "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Christian Duerr",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-12-31",
      "evidence_quote": "De raad van bestuur bevestigt het verstrijken van het bestuursmandaat van de heer Chr\u00EDstian Duerr op december 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Christian Duerr",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-07-26",
      "evidence_quote": "De enige aandeelhouder beslist om de heer Christian Duerr, wonende te Kettelerstrasse 44, 64807 Dieburg in Duitsland te benoemen tot bestuurder van de Vennootschap met ingang van 26 juli 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Christos Andriopoulos",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-01",
      "evidence_quote": "De aandeelhouder beslist om het ontslag te aanvaarden met ingang van 1 mei 2021. De aandeelhouder zal over de uiteindelijke kwijting voor de uitoefening van het mandaat beslissen op de eerstvolgende gewone algemene vergadering.",
      "discharge_granted": false
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Christophe Elichabe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-01",
      "evidence_quote": "De enige aandeelhouder beslist om de heer Benoit Christophe Elichabe, wonende te 5 Place Saint Nizier, 69002 Lyon (Frankrijk) te benoemen tot bestuurder van de Vennootschap met ingang van 1 mei 2021."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Elichabe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-01",
      "evidence_quote": "De raad van bestuur beslist om het dagelijks bestuur van de Vennootschap aan de heer Benoit Elichabe, individueel handelend, te delegeren overeenkomstig artikel 19, b/ van de statuten met ingang van 1 mei 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op ... 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 17 MAART 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. Takeda Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AbbVie N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 2. Amgen N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 3. Eli Lilly Benelux N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 4. Pfizer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Merck N.V.",
      "value": {
        "role": "bestuurder",
        "end_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium NV heeft als vaste vertegenwoordiger de heer Laurerit Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    },
    {
      "type": "officer_appointment",
      "quote": "Caroline Ven CEO, belast met het dagelijks bestuur",
      "value": {
        "role": "CEO, belast met het dagelijks bestuur"
      },
      "object": "e1",
      "subject": "e9"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-04-23 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1820,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie N.V.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen N.V.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux N.V.",
      "attrs": {
        "seat": "Markiesstraat 1, 1000 Brussel"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {
        "seat": "Pleinlaan 17, 1050 Elsene"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "flag": "Name \u0027Laurerit\u0027 appears to be an OCR error for \u0027Laurent\u0027, but preserved as printed.",
      "kind": "person",
      "name": "Laurerit Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Brussel",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (Frankrijk)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, belast met het dagelijks bestuur"
      }
    }
  ]
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "1/2021",
      "value": "2021-01-01",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 17 MARS 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Nomination de: 1. Takeda Belgium S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Amgen S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "date": "2021-03-17",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 1. Merck S.A.",
      "value": {
        "date": "2021-03-17",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Laurent Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-01-01 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1896,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Laurent Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Bruxelles",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (France)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG Bedrijfsrevisoren CVBA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2020-06-19",
      "evidence_quote": "De algemene vergadering beslist en bevestigt de herbenoeming van de vennootschap KPMG Bedrijfsrevisoren CVBA, met maatschappelijke zetel te Luchthaven Brussel Nationaal 1K, 1930 Zaventem, als commissaris van de Vennootschap met ingang vanaf 19/06/2020 voor een termijn van drie (3) jaren."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "value": "Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020",
      "value": "2020-07-22",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 13 JULI 2020",
      "value": "2020-07-13",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 FEBRUARI 2020",
      "value": "2020-02-19",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 JUNI 2020",
      "value": "2020-06-24",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 13 MEI 2020",
      "value": "2020-05-13",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "De raad van bestuur neemt akte van het ontslag van mevrouw Catherine Auguste J. Rutteri ... als algemeen directeur van de vereniging. Dit ontslag zal in werking treden op 1 juli 2020.",
      "value": {
        "role": "algemeen directeur",
        "end_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "Met ingang vanaf 1 juli 2020 wordt mevrouw Ann Maria Marcel Ludo Adriaenseri ... aargesteld als algemeen directeur ad interim van de vereniging.",
      "value": {
        "role": "algemeen directeur ad interim",
        "start_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 24 juni 2020 werd Pfizer ... verkozen tot nieuwe voorzitter van de Raad van Bestuur",
      "value": {
        "role": "Voorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "werd Eli Lilly Benelux ... verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
      "value": {
        "role": "Ondervoorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger mevrouw Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "met als nieuwe vaste vertegenwoordiger mevrouw Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4. Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5. Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6. Merck N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Celgene BVBA",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Algemene Vergadering van 13 mei 2020.",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "artikel 3. Belangeloos doel - voorwerp ... Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "value": "Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 83064,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "Emile Van Becelaerelaan 107, 1170 Watermaal-Bosvoorde",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Brussel",
        "birth_date": "1972-06-18",
        "birth_place": "Parijs (Frankrijk)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene BVBA",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020 - Annexes du Moniteur belge",
      "value": "22/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen o 713 JULI 2020",
      "value": "13/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 FEVRIER 2020",
      "value": "19/02/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "Le Conseil d\u0027administration prend acte de la d\u00E9mission de madame Catherine Auguste J. Rutten ... en tant que directeur g\u00E9n\u00E9ral de l\u0027association. Cette d\u00E9mission entrera en vigueur le 1 juillet 2020.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral",
        "end_date": "2020-07-01"
      },
      "object": null,
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "A partir du 1 juillet 2020, madame Ann Maria Marcel Ludo Adriaensen ... a \u00E9t\u00E9 nomm\u00E9e directeur g\u00E9n\u00E9ral ad interim.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral ad interim",
        "start_date": "2020-07-01"
      },
      "object": null,
      "subject": "e3"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 JUIN 2020",
      "value": "24/06/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020, Pfizer ... a \u00E9t\u00E9 \u00E9lue nouveau Pr\u00E9sident du Conseil d\u0027administration",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "Pfizer, avec en tant que repr\u00E9sentant permanent Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020 ... Eli Lilly Benelux ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "Eli Lilly Benelux, avec en tant que repr\u00E9sentant permanent Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 13 MAI 2020",
      "value": "13/05/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Nomination de : 1. AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "AstraZeneca S.A. ... avec en tant que repr\u00E9sentant permanent madame Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : 1. Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 2. GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 3. Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. ... avec en tant que nouveau repr\u00E9sentant permanent madame Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 4. Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 5. Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 6. Merck S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Celgene SPRL",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 13 mai 2020. Les statuts modifi\u00E9s sont libell\u00E9s comme suit:",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "article 3. But d\u00E9sint\u00E9ress\u00E9 - Objet Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier.",
      "value": "Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier. Parmi les activit\u00E9s concr\u00E8tes men\u00E9es par l\u0027Association en vue de la r\u00E9alisation de son but, on trouve notamment: a)un soutien scientifique, administratif, juridique et organisationnel aux membres... b)l\u0027organisation de toutes activit\u00E9s visant \u00E0 favoriser une meilleure compr\u00E9hension des probl\u00E8mes... c)la promotion... d\u0027une efficiente collaboration entre les membres; d)le d\u00E9veloppement de toutes activit\u00E9s... contribuant directement ou indirectement \u00E0 la r\u00E9alisation du but d\u00E9sint\u00E9ress\u00E9 susmentionn\u00E9...",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 82578,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "avenue Emile Van Becelaere 107, 1170 Watermael-Boitsfort",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Bruxelles",
        "birth_date": "1972-06-18",
        "birth_place": "Paris (France)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene SPRL",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Spasena Ivanova Yotova",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-04-01",
      "evidence_quote": "Ter vervanging van de heer Ronald Rahi beslist de enige aandeelhouder om mevrouw Spasena Ivanova Yotova, geboren op 24 december 1985 in Varna (Bulgarije), met adres te Andreasplein 85, 1058 GD Amsterdam te benoemen als bestuurder van de Vennootschap, en dit met ingang van 1 april 2019."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Ariane Misonne",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-12-01",
      "evidence_quote": "alle bevoegdheden die de Vennootschap aan mevrouw Ariane Misonne heeft toegekend in haar hoedanigheid van gedelegeerd bestuurder te be\u00EBindigen met ingang van 1 december 2018 en om haar dank uit te drukken voor de diensten die mevrouw Ariane Misonne heeft geleverd als gedelegeerd bestuurder",
      "discharge_granted": false
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Christos Andriopoulos",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-12-04",
      "evidence_quote": "de heer Christos Andriopoulos te benoemen als gedelegeerd bestuurder met onmiddellijke ingang"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Christos Andriopoulos",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-12-01",
      "evidence_quote": "De enige aandeelhouder van de Vennootschap besluit bij eenparigheid van de stemmen om de heer Christos Andriopoulos, met woonplaats te Rue de la Gare 42, 1040 Etterbeek, Belgi\u00EB, als bestuurder van de Vennootschap te benoemen voor een periode die eindigt op de gewone algemene vergadering van aandeelh"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ariane Misonne",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-12-01",
      "evidence_quote": "De voorzitster deelde de raad van bestuur mee dat zij ontslag zal nemen als bestuurder van de Vennootschap met ingang van 1 december 2018. De raad van bestuur erkende dit ontslag en drukte haar dank uit voor de diensten die mevrouw Ariane Misonne heeft geleverd als bestuurder van de Vennootschap.",
      "discharge_granted": false
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG Bedrijfsrevisoren Burgerlijke vennootschap onder de vorm van co\u00F6peratieve vennootschap met beperkte aansprakelijkheid",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2017-07-01",
      "evidence_quote": "de beslissing en de bevestiging van de herbenoeming van de vennootschap KPMG Bedrijfsrevisoren Burgerlijke vennootschap onder de vorm van co\u00F5peratieve vennootschap met beperkte aansprakelijkheid (\u0022CVBA\u0022), met maatschappelijke zetel thans te Luchthaven Brussel Nationaal 1K, 1930 Zaventem, als commiss"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "date": "2017-08-16",
      "type": "publication",
      "quote": "-16/08/2017-",
      "value": "16/08/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-08-04",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 / Re\u00E7u le 04 ADUT 2017",
      "value": "04/08/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-03-24",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 24 MARS 2017",
      "value": "24/03/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Nomination de : 1. Merck S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e2",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 2. GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e3",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 3. Janssen-Cilag S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 4. Novartis Pharma S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 5. Sanofi Belgium S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Catherine Rutten CEO charg\u00E9 de la gestion journali\u00E8re",
      "value": {
        "role": "charg\u00E9 de la gestion journali\u00E8re",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e7",
      "_value_raw": {
        "role": "charg\u00E9 de la gestion journali\u00E8re",
        "start_date": "24/03/2017"
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1639,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e5",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e6",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2017-08-16",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad.-16/08/2017-",
      "value": "16/08/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-08-04",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 / Ra\u00E7u le 04 ADUT 2017",
      "value": "04/08/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-03-24",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 24 MAART 2017",
      "value": "24/03/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. Merck N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 2. GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 3. Janssen-Cilag N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 4. Novartis Pharma N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 5. Sanofi Belgium N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
      "value": {
        "role": "CEO belast met het dagelijks bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "CEO belast met het dagelijks bestuur",
        "start_date": "24/03/2017"
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1560,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
        "legal_form": "Vereniging zonder winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Pierre Darriot",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-04-27",
      "evidence_quote": "De Bijzondere Algemene Vergadering stelt vast dat het mandaat als bestuurder van de heer Jean-Pierre Darriot en het mandaat als bestuurder van Mevrouw Marie-Andr\u00E9e Gamache eindigen met ingang van 27.04.2017."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marie-Andr\u00E9e Gamache",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-04-27",
      "evidence_quote": "De Bijzondere Algemene Vergadering stelt vast dat het mandaat als bestuurder van de heer Jean-Pierre Darriot en het mandaat als bestuurder van Mevrouw Marie-Andr\u00E9e Gamache eindigen met ingang van 27.04.2017."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ronald Rahi",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-04-27",
      "evidence_quote": "De Bijzondere Algemene Vergadering heeft beslist om de heer Ronald Rahi, met kantooradres te Brusselsesteenweg 288 te 3090 Overijse, te benoemen tot bestuurder van de vennootschap met ingang vanaf 27.04.2017, voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2016-03-09",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "als bijzondere gevolmachtigde, met recht van substitutie, aangesteld werden: de medewerkers van VZW Securex Ondernemingsloket go-Start, met kantoor te 2000 Antwerpen, Frankrijklei 53-55, aan wie de macht verleend wordt om alle verrichtingen te stellen ten einde de inschrijving van de vennootschap in de Kruispuntbank voor Ondernemingen en haar registratie als BTW-belastingplichtige, te verbeteren en te wijzigen.",
      "holder_kbo": null,
      "holder_name": "VZW Securex Ondernemingsloket go-Start",
      "scope_categories": [
        "KBO",
        "BTW",
        "inschrijving",
        "registratie"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Pierre Darriot",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-02-01",
      "evidence_quote": "De Bijzondere Algemene Vergadering beslist om de heer Jean-Pierre Darriot, wonende te Impasse de Montalet, 69330 Jons, Frankrijk te benoemen tot bestuurder van de vennootschap met ingang vanaf 1/2/2016."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bj\u00F6rn Hermes",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-12-17",
      "evidence_quote": "De bijzondere algemene vergadering stelt vast dat het mandaat als bestuurder van de heer Bj\u00F6rn Hermes eindigt met ingang van 17/12/2015."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marie-Andr\u00E9e Gamache",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-10-01",
      "evidence_quote": "Uit de schriftelijke besluiten van enige aandeelhouder dd.12 oktober 2015 blijkt dat de enige aandeelhouder! beslist heeft om mevrouw Marie-Andr\u00E9e Gamache, wonende te George Brugmannplein 7,1050 Elsene, te benoemen tot bestuurder van de vennootschap met ingang van 1 oktober 2015."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Ariane Misonne",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-10-01",
      "evidence_quote": "Uit de notulen van de vergadering van de raad van bestuur gehouden op 16 oktober 2015 blijkt dat de raad van bestuur heeft beslist om mevrouw Ariane Misonne, wonende te Chemin des Ornois 29, 1380 Lasne, in overeenstemming met artikel 25 van de statuten de algehele vertegenwoordigingsbevoegdheid van "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Uloff Muenster",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-06-30",
      "evidence_quote": "de aandeelhouders hebben vastgesteld dat het mandaat als bestuurder van de heer Uloff Muenster werd be\u00EBindigd met ingang van 30 juni 2015."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ariane Misonne",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-07-01",
      "evidence_quote": "de aandeelhouders hebben beslist om mevrouw Ariane Misonne, wonende te Chemin des Ornois 29, 1380 Lasne, te benoemen tot bestuurder van de vennootschap met ingang van 1 juli 2015."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0403.047.965",
    "name_full": "MERCK",
    "legal_form": "NV"
  }
}